Quantum Machine Learning for Drug Discovery: Taxonomy, Research Challenges, and the Road Ahead
The recent pandemic outbreak has posed significant challenges for medical research, particularly in drug discovery. Machine learning (ML) has become increasingly prevalent in various stages of drug discovery, aiming to support the advancement of new drug research while reducing time and cost investments. Furthermore, the emergence of quantum computing and quantum machine learning (QML) represents a significant advancement in this field, offering the ability to tackle the complex processes involved in drug discovery. This review provides a comprehensive perspective, comparing advanced QML to classical ML in drug discovery applications including drug design, virtual screening, and absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction. Additionally, we summarize the current applications of QML algorithms to real-world datasets utilized in clinical research and drug discovery.
Authors
- Hyundong Shin
- Trung Q. Duong (ORCID: https://orcid.org/0000-0002-4703-4836)
- Octavia A. Dobre (ORCID: https://orcid.org/0000-0001-8528-0512)
- Syed Muhammad Abuzar Rizvi (ORCID: https://orcid.org/0000-0002-1871-4058)
- Duong Hoang Phi Yen
- Brad McNiven
- Thanh Tuan Nguyen
Institutions
- Memorial University of Newfoundland (CA)
- Kyung Hee University (KR)
- Memorial (RU)
- University of Greenwich (GB)
Publication Details
- Journal
- ACM Computing Surveys
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1145/3785660
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00